ATTENTION: Please enable Javascript in your browser for full site functionality.
Skip to navigation Skip to main content Skip to footer

Ticker Update

Updates

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - XOMOLIX 2.5MG/ML SOLUTION FOR INJECTION

Kyowa Kirin Limited is recalling the below batches as a precautionary measure, due to the reports of glass and cellulose fibre contamination, which was identified during stability and reference sample inspection

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-kyowa-kirin-limited-xomolix-2-dot-5-mg-slash-ml-solution-for-injection-el-21-a-slash-15?utm_medium=email&utm_campaign=govuk-notifications&utm_source=3e23300a-19ec-459c-9311-e77b781e4d45&utm_content=immediately   

Pip code

Product description

Supplier

Batch numbers

8350837

XOMOLIX 2.5MG/ML  SOLUTION FOR INJECTION

KYOWA KIRIN

1821A

1919

 

Further information

 

For Stock control enquiries please contact

Karen Murray, Commercial Manager

Telephone: +44 (0) 1896 661665 / Mobile: +44 (0) 7712 001288

Email: karen.murray@kyowakirin.com

 

For Medical information enquiries please contact

Medical Information Direct Line: + 44 (0)1896 664 000

Email: medinfo@kyowakirin.com

 

For Quality information please contact

Martin Smith (Responsible Person)

Telephone: Mobile: +44 7904671807

Email: Martin.Smith@kyowakirin.com.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit..

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - IRBESARTAN-CONTAINING AND LOSARTAN-CONTAINING PRODUCTS

Bristol Laboratories Limited, Brown & Burk UK Ltd and Teva UK Ltd are recalling the below batches of products as a precautionary measure due to contamination with an impurity called 5-(4’-(azidomethyl)- [1,1’-biphenyl]-2yl)-1H-tetrazole, which has mutagenic potential. These batches are being recalled as the level of contamination is above the acceptable limit

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-bristol-laboratories-limited-brown-and-burk-uk-ltd-teva-uk-ltd-irbesartan-containing-and-losartan-containing-products-el-21-a-slash-14?utm_medium=email&utm_campaign=govuk-notifications&utm_source=6bdefacf-875e-4062-aa0b-ebeba6a9dc5d&utm_content=immediately   

Bristol Laboratories Limited

 

Pip code

Product description

Livery

Batch Numbers

1149657

Irbesartan 75 mg Film Coated Tablets

Bristol Laboratories Limited

POM0007

POM0008

POM0009

POM0010

6359616

Irbesartan 75 mg Film Coated Tablets

Bristol Laboratories Limited

POM0007

POM0008

POM0009

POM0010

1149715

Irbesartan 150 mg Film Coated Tablets

Bristol Laboratories Limited

PON0005

PON0006

PON0007

PON0008

PON0009

6359624

Irbesartan 150 mg Film Coated Tablets

Bristol Laboratories Limited

PON0005

PON0006

PON0007

PON0008

PON0009

1176536

Irbesartan 150 mg Film Coated Tablets

Bristol Laboratories Limited

PON0005

PON0006

PON0007

PON0008

PON0009

1149665

Irbesartan 300 mg Film Coated Tablets

Bristol Laboratories Limited

POO0005

6359608

Irbesartan 300 mg Film Coated Tablets

Bristol Laboratories Limited

POO0005

1176544

Irbesartan 300 mg Film Coated Tablets

Bristol Laboratories Limited

POO0005

Brown and Burk UK Limited

 

Pip code

Product description

Livery

Batch Numbers

1149657

Irbesartan 75 mg Film Coated Tablets

Brown and Burk UK Limited

IAAG017

IAAG018

IAAG019

IAAG022

IAAG023

6359616

Irbesartan 75 mg Film Coated Tablets

Brown and Burk UK Limited

IAAG017

IAAG018

IAAG019

IAAG022

IAAG023

1149715

Irbesartan 150 mg Film Coated Tablets

Brown and Burk UK Limited

IABG033

IABG034

IABG035

IABG037

IABG038

IABG039

IABG051

6359624

Irbesartan 150 mg Film Coated Tablets

Brown and Burk UK Limited

IABG033

IABG034

IABG035

IABG037

IABG038

IABG039

IABG051

1176536

Irbesartan 150 mg Film Coated Tablets

Brown and Burk UK Limited

IABG033

IABG034

IABG035

IABG037

IABG038

IABG039

IABG051

1149665

Irbesartan 300 mg Film Coated Tablets

Brown and Burk UK Limited

IACG027

IACG028

IACG032

IACG035

IACG036

IACG037

6359608

Irbesartan 300 mg Film Coated Tablets

Brown and Burk UK Limited

IACG027

IACG028

IACG032

IACG035

IACG036

IACG037

1176544

Irbesartan 300 mg Film Coated Tablets

Brown and Burk UK Limited

IACG027

IACG028

IACG032

IACG035

IACG036

IACG037

1186840

Irbesartan/Hydrochlorothiazide 150mg/12.5mg Film Coated Tablets,

Brown and Burk UK Limited

IZAG020

8382673

Irbesartan/Hydrochlorothiazide 150mg/12.5mg Film Coated Tablets,

Brown and Burk UK Limited

IZAG020

1186857

Irbesartan/Hydrochlorothiazide 300mg/12.5mg Film Coated Tablets,

Brown and Burk UK Limited

IZCG010

8382681

Irbesartan/Hydrochlorothiazide 300mg/12.5mg Film Coated Tablets,

Brown and Burk UK Limited

IZCG010

1186832

Irbesartan/Hydrochlorothiazide 300mg/25mg Film Coated Tablets

Brown and Burk UK Limited

IZBG008

8382665

Irbesartan/Hydrochlorothiazide 300mg/25mg Film Coated Tablets

Brown and Burk UK Limited

IZBG008

Teva UK Limited

 

Pip code

Product description

Livery

Batch Numbers

1178870

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

8023574

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

1207570

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

1153626

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

1150150

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

1205707

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

8113706

Losartan potassium 50mg Film Coated Tablets

Teva UK Ltd

108885

1178888

Losartan potassium 100mg Film Coated Tablets

Teva UK Ltd

106077

8023566

Losartan potassium 100mg Film Coated Tablets

Teva UK Ltd

106077

1207588

Losartan potassium 100mg Film Coated Tablets

Teva UK Ltd

106077

1153618

Losartan potassium 100mg Film Coated Tablets

Teva UK Ltd

106077

1150168

Losartan potassium 100mg Film Coated Tablets

Teva UK Ltd

106077

 

 

Further Information

 

Bristol Laboratories Limited

For more information or medical information queries please contact notifications@bristol-labs.co.uk

For supply queries, please contact notifications@bristol-labs.co.uk

 

Brown & Burk UK Ltd

For more information or medical information queries please contact pv@bbukltd.com

For supply queries, please contact customercare@bbukltd.com or 0203 384 7188

 

Teva UK Limited

For more information or medical information queries please contact Teva Medical Information at

medinfo@tevauk.com or 0207 540 7117

For supply queries, please contact Teva Customer Solutions at customer.services@tevauk.com or

0800 590502

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 1 RECALL

CLASS 1 RECALL - CO-CODAMOL EFF TAB 30/500MG

Zentiva Pharma UK Limited is recalling the below batch of Co-Codamol 30/500 Effervescent Tablets as a precautionary measure due to an issue with the homogeneity of the batch. This issue means that there is the potential for some tablets to have too little active ingredients (codeine phosphate and paracetamol) in them and some tablets to contain too much active ingredients. The current investigation has highlighted that tablets have been identified where the content of both codeine and paracetamol is less than the label claim.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/national-patient-safety-alert-class-1-medicines-recall-notification-recall-of-co-codamol-30-slash-500-effervescent-tablets-batch-1k10121-zentiva-pharma-uk-ltd-due-to-precautionary-risk-of-causing-overdose-natpsa-slash-2021-slash-0?utm_medium=email&utm_campaign=govuk-notifications&utm_source=33da5f41-be1d-4bf9-a5ef-3016b2913e73&utm_content=immediately

Pip code

Product description

Livery

Batch Numbers

1132463

CO-CODAMOL EFF TAB 30/500MG

ZENTIVA PHARMA UK

1K10121

1096700

CO-CODAMOL EFF TAB 30/500MG

ZENTIVA PHARMA UK

1K10121

 

We would like to draw your attention to the following quote from the MHRA: MHRA Chief Quality and Access officer, Dr Samantha Atkinson, said:

Patient safety is always our priority. It is vitally important that people urgently check their packs of Zentiva Pharma UK Ltd Co-codamol 30/500 Effervescent Tablets and if the batch number corresponds to 1K10121, they should stop using them and return them to their pharmacy for a replacement immediately.

 

For more information or medical information queries please contact 0800 0902408 or email UKMedInfo@zentiva.com.

 

For supply queries, please contact 0844 8793188 or email gfd-customerservices@zentiva.com. Please contact claims@zentiva.com to arrange return and replacement of affected packs in your possession.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

Please note that anything not returned to us, or notified to us, within 3 months of this notification, cannot be reimbursed by way of a credit.

SUB-TYPE: COMPANY-LED RECALL

09.06.2021

COMPANY-LED DRUG ALERT – Alliance do not stock

The importer and distributor of the below products (Eaststone Limited) has informed us of reports that two affected batches may be contaminated with mould. Therefore, these batches are being recalled as a precautionary measure. This recall is being issued as a company-led recall due to the limited number of packs distributed, and Eaststone Limited have full traceability of the onward distribution by their customers.

 

Please can you ensure that your stores quarantine the product listed below

Pip code

Product

Supplier

Affected Batches

Alliance do not stock

Noidecs T20/C4 (THC 20%; CBD 4%) Sativa Cannabis Flower

Eaststone Limited

14NS2021002

Alliance do not stock

Noidecs T20/C4 (THC 20%; CBD 4%) Indica Cannabis Flower

Eaststone Limited

14NI2021002

Alliance do not stock these products and therefore we are not accepting stock returns.

 

Company Contact for medical information enquiries

For medical information enquiries, please contact: Omair Sattar

Email: omair.sattar@eaststone.co.uk

Tel: 01942 841 704

 

Company Contact for stock enquiries

For stock information enquiries, please contact: Omair Sattar

Email: omair.sattar@eaststone.co.uk

Tel: 01942 841 704

SUB-TYPE: CLASS 3 RECALL

CLASS 3 RECALL - CARBIMAZOLE TAB 10MG & 15MG

Advanz Pharma is recalling the below batches of Carbimazole tablets as a precautionary measure, due to an out of specification observation for tablet appearance of samples during routine stability testing. Based on the investigation performed, the observed defect was related to oxidation of the excipient red iron oxide on the surface of the tablets, due to a lack of proper mixing during the manufacturing process. There is no safety or efficacy issues as a result of this observation.

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-3-medicines-recall-intrapharm-laboratories-ltd-kolanticon-gel-500ml-el-21-a-slash-01?utm_medium=email&utm_campaign=govuk-notifications&utm_source=1c3cadd1-c259-4e77-b3e8-c13faf584fe2&utm_content=immediately  

Pip code

Product description

Supplier

Batch Numbers

8127730

CARBIMAZOLE TAB 10MG

ADVANZ PHARMA

120963

121025

1233931

CARBIMAZOLE TAB 10MG

ADVANZ PHARMA

120963

121025

8127938

CARBIMAZOLE TAB 15MG

ADVANZ PHARMA

120967

121028

Further Information

 

For more information or medical information queries please contact +44 (0) 8700 70 30 33 , or email medicalinformation@advanzpharma.com.

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: COMPANY-LED RECALL

Company Led - DRUG ALERT - LYSAKARE 25 G / 25 G SOLUTION FOR INFUSION

Advanced Accelerator Applications Ltd is recalling the below batch of LysaKare 25 g / 25 g solution for infusion (PLGB 35145/0005) as it was identified during the inspection process by the manufacturer that a small number of bags were observed to be leaking..”

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/company-led-medicines-recall-lysakare-25-g-slash-25-g-solution-for-infusion-plgb-35145-slash-0005?utm_medium=email&utm_campaign=govuk-notifications&utm_source=125027c5-2625-4ae7-a249-7c9dc4b72260&utm_content=immediately   

Pip code

Product description

Supplier

Batch numbers

Alliance do not stock

LYSAKARE 25 G / 25 G SOLUTION FOR INFUSION

ADVANCED ACCELERATOR APPLICATIONS (UK & IRELAND) LTD

210155

 

Alliance do not stock this product and therefore we are not accepting stock returns.

 

Company contact for medical information enquiries

For medical information enquiries, please contact: Advanced Accelerator Applications (UK & Ireland) Ltd infomed@adacap.com.

 

Company contact for stock enquiries

For stock information enquiries contact Advanced Accelerator Applications (UK & Ireland) Ltd by emailing: customersvc.aaauk@novartis.com, tel. +44(0)20 72585200

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: FIELD SAFETY NOTICE

COMPANY LED FIELD SAFETY NOTICE- ARTELAC REBALANCE 10ML

The product recall for the affected batch is due to the incorrect shipment of products intended for the Belgian market to the UK/Ireland markets. As a result part of the shipments for batch 520 of Artelac Rebalance contain products with German/French/Dutch labelling. The labelling and Instructions for Use should be understood by all users in their country official language. Therefore German/French/Dutch labelled products must not be distributed in UK or Ireland

MHRA drug alert link: N/A   

Pip code

Product description

Supplier

Batch numbers

3620549

ARTELAC REBALANCE 10ML

BAUSCH & LOMB

LOT 520

 

If you have any questions, please contact Bausch + Lomb Customer Service.

Email: Pharma_CS@bausch.com

Phone: 0845 602 2350

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

If you have any questions, then please contact your local Service Centre Customer Services team.

SUB-TYPE: CLASS 2 RECALL

CLASS 2 RECALL - BRICANYL AMP 0.5MG/1ML

AstraZeneca UK Limited is recalling the below batch of Bricanyl 0.5mg/ml solution for injection or infusion as a precautionary measure due to out of specification results for a routinely tested known impurity during stability testing

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-2-medicines-recall-astrazeneca-uk-limited-bricanyl-injection-0-dot-5-mg-slash-ml-solution-for-injection-or-infusion-pl-17901-slash-0112-el-21-a-slash-12?utm_medium=email&utm_campaign=govuk-notifications&utm_source=42605459-ef94-4b7e-bb39-33e83dbc6d74&utm_content=immediately   

Pip code

Product description

Supplier

Batch Numbers

0035188

BRICANYL AMP 0.5MG/1ML

ASTRAZENECA

F1029-1

 

Please note that Alliance Healthcare do not stock and we are therefore not accepting stock returns.

 

For more information or medical information queries please contact

 

Tel: +44 (0) 0800 783 0033

 

Email: medical.informationuk@astrazeneca.com

 

For supply queries, please contact

 

Tel: +44 (0) 800 783 0033 (option 1)

 

Email: supply.chain@astrazeneca.com.

SUB-TYPE: FIELD SAFETY NOTICE

FIELD SAFETY NOTICE - HISTOACRYL ADH TISSUE BLU

: B. Braun have detected new additional batches where the adhesive could not polymerize completely after its application. The tested products did not show the normal curing behaviour, providing lower adhesive forces than expected.

MHRA drug alert link: N/A

Pip code

Product description

Supplier

Batch numbers

0416024

HISTOACRYL ADH TISSUE BLU

BRAUN B MEDICAL

220395N2

220401N1

220403N1

220414N1

220411N2

220444N2

220414N2

220444N1

220444N3

220445N3

220451N1

220445N1

220481N1

220481N2

220481N3

220484N1

220484N3

 

 

Please return all affected stock to your original supplier for credit. Unfortunately we can only accept stock purchased from us (Alliance Healthcare Distribution Limited). Any other stock will be returned to your stores/Pharmacies.

 

If you have any questions, then please contact your local Service Centre Customer Services team

SUB-TYPE: CLASS 4 CAUTION IN USE

Class 4 Drug Caution in use - SYONELL 250MG & 500MG GASTRO-RESISTANT TABLETS

: Lupin Healthcare (UK) Limited has informed us of a discrepancy with the product packaging for several batches of Syonell 250mg Gastro-Resistant Tablets and Syonell 500mg Gastro-Resistant Tablets. This discrepancy relates to the incorrect amount of active pharmaceutical ingredient (valproate semisodium) printed on the outer packaging

MHRA drug alert link: https://www.gov.uk/drug-device-alerts/class-4-medicines-defect-information-syonell-250mg-gastro-resistant-tablets-pl-35507-slash-0191-syonell-500mg-gastro-resistant-tablets-pl-35507-slash-0192-el-21-a-slash-11?utm_medium=email&utm_campaign=govuk-notifications&utm_source=58b8fb90-a905-45be-8b0f-5c608a23c4ba&utm_content=immediately

Pip code

Product description

Supplier

Batch Numbers

4140760

VALPROIC ACID (SYONELL) 250MG

LUPIN HEALTHCARE (UK)  LTD

PLEASE FOLLOW MHRA LINK

4140778

VALPROIC ACID (SYONELL) 500MG

LUPIN HEALTHCARE (UK)  LTD

PLEASE FOLLOW MHRA LINK

 

This may have been supplied by AHDL. Unfortunately we are not providing specific batch information you will  be required to follow the instructions as per the drug alert.

 

This is a caution in use only we are not accepting stock returns.

 

For more information or medical information queries, please contact: +44 (0) 1565 751 378 Option 1 or Pharmacovigilance Department at EU-PV@lupin.com

 

For stock control queries, please contact: 44 (0) 1565 751 378 Option 2 or information@lupin.com

 

If you have any questions, then please contact your local Service Centre Customer Services team.